Accessibility Tools

45 min overview on the 2019 current FDA regulatory landscape for regenerative medicine. I also discuss the ethical concerns and recent regulatory and legal actions in the USA.

Comments

    Post a comment

    Your email address will not be published. Fields marked (*) are mandatory.